What is the recommended treatment for anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anaphylaxis Treatment Protocol

Epinephrine is the first-line and most critical treatment for anaphylaxis and should be administered immediately upon recognition of anaphylactic symptoms. 1, 2

First-Line Treatment

  • Epinephrine administration:
    • Adults and children ≥30 kg: 0.3-0.5 mg of 1:1000 concentration (1 mg/mL) IM in the anterolateral thigh
    • Children <30 kg: 0.01 mg/kg (maximum 0.3 mg) of 1:1000 concentration IM in the anterolateral thigh 1
    • Delayed administration may be fatal 3
    • Prepare for potential second dose if symptoms persist or worsen 1

Positioning and Supportive Care

  • Place patient in supine position with legs elevated (or Trendelenburg position for severe hypotension) 1
  • Establish IV access immediately
  • For hypotension: Administer fluid resuscitation with 1-2 liters of normal saline at 5-10 mL/kg in first 5 minutes 1
  • Provide supplemental oxygen for respiratory symptoms or after multiple epinephrine doses 1
  • Continuous cardiac monitoring, especially for high-risk patients 1

Adjunctive Therapies (Only after epinephrine administration)

  1. Antihistamines:

    • H1 antagonists: Diphenhydramine 25-50 mg IV/IM/PO for cutaneous symptoms 1
    • H2 blockers: Famotidine 20 mg IV for urticaria 1
  2. Bronchodilators:

    • Albuterol 2.5-5 mg via nebulizer for persistent bronchospasm 1
  3. Corticosteroids:

    • Methylprednisolone 1-2 mg/kg IV every 6 hours or
    • Prednisone 0.5 mg/kg orally
    • May help prevent protracted or biphasic reactions 1

Monitoring and Observation

  • Monitor vital signs, including blood pressure, heart rate, and oxygen saturation 1
  • Observe patients until signs and symptoms have fully resolved 1
  • Observation periods:
    • High-risk patients: Extended observation up to 6+ hours or hospital admission 1
    • Low-risk patients: May be discharged after 1-hour asymptomatic observation 1
    • 6-19% of pediatric patients require a second dose of epinephrine 1

High-Risk Factors for Biphasic Reactions

  • Severe initial anaphylactic reaction
  • Requirement of more than one epinephrine dose
  • Wide pulse pressure
  • Unknown anaphylaxis trigger
  • Drug-triggered anaphylaxis in children 1
  • Coexisting asthma, mast cell disorders, older age, cardiovascular disease 4

Patient Education and Follow-up

  • Prescribe epinephrine auto-injector to be carried at all times 3
  • Educate on proper use of epinephrine auto-injector 1, 3
  • Instruct to activate emergency response system (call 911) for any recurrence 1
  • Refer to allergist/immunologist for trigger identification and long-term management 1

Common Pitfalls to Avoid

  • Delaying epinephrine administration - this is the most common and dangerous error 5
  • Using IV route for initial epinephrine (IM is preferred except in severe shock) 6
  • Relying on antihistamines or corticosteroids as first-line treatment 4
  • Discharging patients too early without adequate observation
  • Failing to prescribe auto-injector or provide proper education on its use
  • Overlooking the need for allergist referral for long-term management

Remember that epinephrine is the cornerstone of anaphylaxis management, and no contraindications exist to its use in a life-threatening anaphylactic reaction 3.

References

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Research

Anaphylaxis: Recognition and Management.

American family physician, 2020

Research

Anaphylaxis: Emergency Department Treatment.

Immunology and allergy clinics of North America, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.